2016 - 2026
Need a report that reflects how COVID-19 has impacted this market and its growth?
The global white biotech market was valued at USD 641.68 billion in 2020 and is projected to witness a CAGR of 15.14% during the forecast period (2021 - 2026).
COVID-19 has provided a huge stimulus to the white biotech market. Massive efforts to develop vaccines, deploy test kits, develop highly predictive antibody tests, repurpose existing anti-viral drugs, and develop new drugs are causing billions of dollars to flow toward many biotech companies.
In 2021, the biotech sector may have a valuation at or above than the valuation it had in late 2019. Pre-clinical work is expected to be robust. Clinical trials may be near the volume of a year earlier. The regulatory review of clinical trials may be more efficient.
Furthermore, major pharmaceutical market giants are actively involved in product innovation and mergers and acquisitions with small-large pharmaceutical companies in order to make a stronghold on the white biotech market in the future.
Thus, the global COVID-19 pandemic has made a significant impact on the white biotechnology market in terms of innovation in the pharmaceutical industry, which is indicating a fruitful market growth of the category.
Rising consumer demand for green chemicals, majorly in developed regions like North America and Europe who are willing to pay a higher price or a green premium for numerous renewable products, is expected to push manufacturers to employ white biotechnology processes as opposed to traditional chemical manufacturing.
In addition, the rising need from various consumer industries, including automotive and consumer goods, to meet sustainability targets is expected to fuel technology demand over the forecast period.
Industrial biotechnology or white biotechnology is one of the most promising approaches to pollution prevention, resource conservation, and cost reduction. It is often referred to as the third wave in biotechnology. For example, the use of white biotechnology can lead to the reduction of carbon dioxide emissions by as much as 50%, energy consumption by 20%, and water consumption by 75%.
Scope of the Report
White biotechnology, also known as industrial biotechnology, involves the use of enzymes and microorganisms to make bio-based products in sectors as varied as chemicals, food and feed, healthcare, detergents, paper and pulp, textiles and bioenergy. The market studied is segmented on the basis of type, application, and geography. Based on type, the global white biotech market report is segmented into biofuels, biomaterials, biochemicals, and industrial enzymes. Based on application, the market report is segmented into chemicals, pharmaceuticals, food and beverages, feed, and other applications. By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. For each segment, the market sizing and forecasts have been done on the basis of value (in USD million) and volume (in million ton)
|Food and Beverages|
Key Market Trends
Wide Application in Market with Diverse Functionality
The growing awareness about the numerous benefits associated with the application of white biotechnology, such as eco-friendly, reduced manufacturing costs, low wastage generation, and maximum raw material consumption, among others, has boosted the demand for white biotechnology among end-users in the past couple of years. For instance, in pulp and paper production and bleaching, white biotechnology has led to the reduction of chlorine chemicals application by 10-15%. In addition, the process is more efficient, consuming 40% less energy than the traditional manufacturing process. Thus, it makes an important contribution to sustainability and optimum utilization of raw material, thereby reducing negative impacts on the environment while gaining maximum profit from the final product.
In addition, the rising need from various high-end industries, including automotive and consumer goods, to meet sustainability targets is boosting the demand for biofuels across the world.
To understand key trends, Download Sample Report
Asia-Pacific is the Fastest-Growing Region in White Biotech Market
China’s biotech industry has grown rapidly over the past decade, and it is dominated by medical technologies and biologics. The growth is escalated by the biotechnologically altered food ingredients in the market. Thus, players are strategically investing in the local companies.
For instance, in 2021, BASF Venture Capital (BVC) invested in Bota Biosciences Ltd (Bota Bio), an industrial synthetic biotech company located in Hangzhou, China, which develops next-generation biotechnology platforms, enabling sustainable and economical production of high-value products for a broad array of industrial applications, like sweetener, vitamins, personal care, or crop protection products.
In addition to the above-mentioned industrial applications, white biotech has paved great opportunity in Japan's functional food and beverage segment too due to the increased consumer inclinational toward food and beverage with high nutritional claims. Thus, biochemicals and industrial enzymes are paving great opportunity in the country’s food and beverage domain.
In 2020, DuPont Nutrition & Biosciences (DuPont) launched Powerfresh Special and Powersoft Cake 8010 in Japan, its latest enzyme range for sweet baked goods.
To understand geography trends, Download Sample Report
The global white biotech market is highly competitive, with a strong presence of regional and global players in the market, where demand is mostly driven by more adaptation toward consumer awareness on sustainability, efficient productivity, and others. Hence, the players operating in the market are trying to position themselves according to the demographic group.
Further, prominent players like Corbion, ADM, and DuPont in the market have been focusing on developing new and innovative products by targeting the new formulation for the market, thereby engineering the various unexplored microorganisms in the market.
In November 2020, EUCODIS Bioscience and Biosynth Carbosynth signed a new distribution agreement for EUCODIS enzyme products.
In November 2019, Dupont Industrial Biosciences launched Leiden Bio Science Park in Oegstgeest, the Netherlands. The capacity of the new site in Oegstgeest doubled the potential for growth of the current employee base, with the potential of creating an additional 100 jobs at the facility, including research and development, application development, marketing, sales and customer service. The building served as the new EMEA (Europe, Middle East and Africa) headquarters for DuPont Industrial Biosciences.
In June 2018, DSM introduced BakeZyme AAA. The solution enables bakeries to reduce ascorbic acid in their recipes while maintaining the ideal bread texture and volume
Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter's Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Volume - million ton and Value - USD billion)
5.1 By Type
5.1.4 Industrial Enzymes
5.2 By Application
5.2.3 Food and Beverages
5.2.5 Other Applications
5.3.1 North America
126.96.36.199 United States
188.8.131.52 Rest of North America
184.108.40.206 United Kingdom
220.127.116.11 Rest of Europe
18.104.22.168 Rest of Asia-Pacific
5.3.4 Rest of the World
22.214.171.124 South America
126.96.36.199 Middle East & Africa
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Most Active Companies
6.2 Most Adopted Strategies
6.3 Market Share Analysis
6.4 Company Profiles
6.4.1 EUCODIS Bioscience GmbH
6.4.3 Koninklijke DSM NV
6.4.4 BASF SE
6.4.5 Evonik Industries AG
6.4.6 Lonza Group Ltd
6.4.7 Laurus Labs
6.4.8 Corbion NV
6.4.10 Archer Daniels Midland Company
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
8. IMPACT OF COVID-19 ON THE MARKET
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The White Biotech Market market is studied from 2016 - 2026.
What is the growth rate of White Biotech Market?
The White Biotech Market is growing at a CAGR of 15.14% over the next 5 years.
Which region has highest growth rate in White Biotech Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in White Biotech Market?
North America holds highest share in 2020.
Who are the key players in White Biotech Market?
- Eucodis Bioscience GMBH
- Koninklijke DSM NV
- BASF SE
- Evonik Industries AG
Are the major companies operating in White Biotech Market.